Jane Street’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$102K Sell
29,170
-68,793
-70% -$261K ﹤0.01% 10583
2026
Q1
$378K Sell
97,963
-51,784
-35% -$204K ﹤0.01% 8693
2025
Q4
$589K Sell
149,747
-10,745
-7% -$47.5K ﹤0.01% 7322
2025
Q3
$749K Buy
160,492
+132,648
+476% +$480K ﹤0.01% 6938
2025
Q2
$86.6K Buy
27,844
+13,389
+93% +$43.2K ﹤0.01% 9011
2025
Q1
$48.9K Sell
14,455
-61,424
-81% -$287K ﹤0.01% 9004
2024
Q4
$430K Sell
75,879
-8,773
-10% -$56.6K ﹤0.01% 7099
2024
Q3
$495K Sell
84,652
-108,141
-56% -$786K ﹤0.01% 7192
2024
Q2
$1.52M Buy
192,793
+151,274
+364% +$1.27M ﹤0.01% 4977
2024
Q1
$387K Buy
+41,519
New +$351K ﹤0.01% 7137
2023
Q3
Sell
-45,658
Closed -$523K 9488
2023
Q2
$523K Sell
45,658
-127,258
-74% -$1.32M ﹤0.01% 6254
2023
Q1
$1.33M Buy
172,916
+147,847
+590% +$1.18M ﹤0.01% 4493
2022
Q4
$153K Buy
+25,069
New +$142K ﹤0.01% 7851
2022
Q3
Sell
-17,124
Closed -$110K 10560
2022
Q2
$102K Sell
17,124
-63,946
-79% -$432K ﹤0.01% 8629
2022
Q1
$618K Buy
81,070
+67,383
+492% +$301K ﹤0.01% 7083
2021
Q4
$37K Buy
+13,687
New +$46.7K ﹤0.01% 9641
2021
Q1
Sell
-17,595
Closed -$126K 9642
2020
Q4
$126K Buy
+17,595
New +$169K ﹤0.01% 7135
2019
Q4
Sell
-12,302
Closed -$212K 5842
2019
Q3
$212K Buy
+12,302
New +$258K ﹤0.01% 4590

Other funds holding VYGR

Jane Street's VYGR Position: Q2 2026 in Review

Jane Street reduced its Voyager Therapeutics (VYGR) stake by 70% in Q2 2026, selling an estimated $261K and leaving 29,170 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #10583.

Jane Street first reported a position in VYGR in Q3 2019 and has held it in 18 quarters since. The position peaked at $1.52M in Q2 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Jane Street held 29,170 shares of Voyager Therapeutics worth $102K as of Q2 2026.
  • Jane Street sold 68,793 Voyager Therapeutics shares in Q2 2026, an estimated $261K.
  • Voyager Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10583 holding.
  • Jane Street first reported a position in Voyager Therapeutics in Q3 2019 and has held it in 18 quarters since.
  • Jane Street's Voyager Therapeutics position peaked at $1.52M in Q2 2024.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.